Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2013
03/21/2013WO2013037118A1 Prostate cancer biomarkers, therapeutic targets and uses thereof
03/21/2013WO2013037068A1 Method for treatment of disorders of the gastrointestinal system
03/21/2013WO2013037066A1 Ocab-based tools for screening of therapeutic agents, treating and diagnosing heart disease associated with cardiac remodeling
03/21/2013WO2013037065A1 Microrna inhibitors
03/21/2013WO2013037046A1 Method and system for amplification of nucleic acids in microfluidic volume hydrogels
03/21/2013WO2013036993A1 Detection of viral infection
03/21/2013WO2013016280A3 Compositions and methods for selecting aptamers
03/21/2013WO2013013066A3 Methods for assessing genomic instabilities in tumors
03/21/2013WO2013012927A3 Oligodendroglioma driver genes
03/21/2013WO2013011131A3 Pluripotent tendon and ligament perivascular cells
03/21/2013WO2013009705A3 Biomarkers, methods, and compositions for inhibiting a multi-cancer mesenchymal transition mechanism
03/21/2013WO2013006824A3 Polymer particles, nucleic acid polymer particles and methods of making and using the same
03/21/2013WO2013003489A3 Method for genome complexity reduction and polymorphism detection
03/21/2013WO2012174496A9 Method for purification and identification of sperm cells
03/21/2013WO2012174225A3 Isolation, expansion and use of autologous pluripotent stem cells
03/21/2013WO2012168448A3 Complex sets of mirnas as non-invasive biomarkers for dilated cardiomyopathy
03/21/2013WO2012166630A3 In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes
03/21/2013WO2012161502A3 Manufacturing method for silica encapsulated single-enzyme nanoparticles and single-enzyme nanoparticles mannufactured by means of method
03/21/2013WO2012159063A3 Gravity flow fluidic device for nucleic acid extraction
03/21/2013WO2012151563A3 Device and method for identifying microbes and counting microbes and determining antimicrobial sensitivity
03/21/2013WO2012151560A3 Methods for detecting nucleic acid sequence variants
03/21/2013WO2012151527A3 Conductive patterns and methods for making conductive patterns
03/21/2013WO2012151328A3 Spatial sequestration of dynamic nucleic acid circuits
03/21/2013WO2012151192A3 Molecular diagnostics platform
03/21/2013WO2012150835A3 Detection of target nucleic acid sequences by po cleavage and hybridization
03/21/2013WO2012149350A3 Genes associated with post relapse survival and uses thereof
03/21/2013WO2012145730A3 Integrated device for nucleic acid detection and identification
03/21/2013WO2012145535A3 Animal model of human cancer and methods of use
03/21/2013WO2012115926A3 Microfluidic device-based nucleic acid purification method
03/21/2013WO2012112685A3 Compositions and methods for diagnosing ovarian cancer
03/21/2013WO2012080541A8 Novel reverse transcriptases of human immunodeficiency virus type 1 group o
03/21/2013WO2004059279A8 High-sensitivity assays for pathogen detection using metal-enhanced fluorescence
03/21/2013US20130074218 Method for optimising gene expression using synonymous codon optimisation
03/21/2013US20130074201 Cancer-specific genetic rearrangements
03/21/2013US20130072748 Methods for assessing endometrium receptivity of a patient
03/21/2013US20130072572 New Signaling Molecule Involved in Ultraviolet Damage to Skin
03/21/2013US20130072545 MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT
03/21/2013US20130072544 Detection of hbx/8p11 hybrid sequence in human hepatocellular carcinoma
03/21/2013US20130072429 Assays and methods using biomarkers
03/21/2013US20130072428 Methods and Compounds Regulating the Erythroid Response to Iron Deficiency
03/21/2013US20130072403 Sperm-specific cation channel, catsper3, and uses therefor
03/21/2013US20130072401 Method and kit for the prognosis of colorectal cancer
03/21/2013US20130072399 Method and kit for discriminating between breast cancer and benign breast disease
03/21/2013US20130072393 Pancreatic cancer markers, and detecting methods, kits, biochips thereof
03/21/2013US20130072392 Compositions, Kits, and Methods for Identification, Assessment, Prevention, and Therapy of Cancer
03/21/2013US20130072389 Theranostic and diagnostic methods using sparc and hsp90
03/21/2013US20130071951 Methods and compositions for determining the purity of chemically synthesized nucleic acids
03/21/2013US20130071919 Method of selecting induced pluripotent stem cell
03/21/2013US20130071915 Microwell structures for chemically-sensitive sensor arrays
03/21/2013US20130071880 Dna amplification apparatus and method
03/21/2013US20130071872 Device and method for single-used matrix sampling
03/21/2013US20130071871 Enzymatic determination of lithium ions using phosphoglucomutase
03/21/2013US20130071870 Method for Determining the Stability of Organic Methyleneamines in the Presence of Semicarbazide-Sensitive Amine Oxidase
03/21/2013US20130071869 Analysis Compensation Including Segmented Signals
03/21/2013US20130071868 Mutant lactate oxidase with increased stability and product, methods and uses involving the same
03/21/2013US20130071853 Methods for identifying compositions that alter wildtype expression of genes and proteins in a plant cell
03/21/2013US20130071852 Controls for Detecting Methicillin Resistant Staphylococcus Aureus (MRSA)
03/21/2013US20130071851 Moving microdroplets in a microfluidic device
03/21/2013US20130071850 Waveguide-based optical scanning systems
03/21/2013US20130071848 One-step method for quantitative determination of uracil in DNA by real-time PCR
03/21/2013US20130071847 Methods and materials for determining the source of waste
03/21/2013US20130071846 Kit and method
03/21/2013US20130071845 Identification of human mouse double minute 2 homolog nucleotide sequences
03/21/2013US20130071844 Method for detecting target base sequence using competitive primer
03/21/2013US20130071843 Methods, probe sets, and kits for detection of deletion of tumor suppressor genes by fluorescence in situ hybridization
03/21/2013US20130071842 Hypermethylation Biomarkers for Detection of Head and Neck Squamous Cell Cancer
03/21/2013US20130071841 Translocation and mutant ros kinase in human non-small cell lung carcinoma
03/21/2013US20130071839 Systems and methods for detecting biomarkers of interest
03/21/2013US20130071838 Peptide nucleic acid probes for analysis of certain staphylococcus species
03/21/2013US20130071836 Colon cancer biomarker discovery
03/21/2013US20130071835 Qualitative and Quantitative Analytical Method for Analyzing the Activity Type of an Enzyme that is Activated by Proteolysis
03/21/2013US20130071834 Compositions and methods useful for hcv infection
03/21/2013US20130071833 Means and methods for distinguishing fecv and fipv
03/21/2013US20130071495 Inhibitors of glycogen synthase kinase 3 for use in therapeutic methods and screening method relating thereto
03/21/2013US20130071483 VACCINE PRODUCED USING OPTIMIZED IMMOBILIZATION ANTIGEN cDNA OF CRYPTOCARYON IRRITANS AND PRODUCING METHOD AND USE THEREOF
03/21/2013US20130071421 Turkey viral hepatitis virus and uses thereof
03/21/2013US20130071418 Physicochemical (PCP) Based Consensus Sequences and Uses Thereof
03/21/2013US20130071408 Methods for Diagnosis and Treatment of Non-Insulin Dependent Diabetes Mellitus
03/21/2013US20130071407 Methods for modulating hematopoiesis and vascular growth
03/21/2013US20130071382 Egfr mutations
03/21/2013US20130071378 Sir2 activity
03/21/2013US20130071374 RNA Interferases and Methods of Use Thereof
03/21/2013US20130071373 Methods for the diagnosis and therapy of retinitis pigmentosa
03/21/2013US20130071370 Inhibitors of micro-rnas for use for preventing and/or attenuating skin ageing and/or for hydrating skin
03/21/2013US20130071332 Labeled molecular imaging agents and methods of use
03/21/2013US20130071330 Methods of identifying agents effective to treat cognitive decline and diseases associated therewith
03/21/2013DE112011101618T5 Verwendung von Nanoporen-Arrays zur Multiplex-Sequenzierung von Nukleinsäuren Use of nanopore arrays for multiplex sequencing of nucleic acids
03/21/2013DE102011053741A1 Verfahren zum Überprüfen der Selbstheilung durch das Immunsystem eines mit humanen Papillomviren infizierten Menschen Method for checking the self-healing by the immune system of an infected with human papillomavirus people
03/21/2013CA2849023A1 Probe:antiprobe compositions for high specificity dna or rna detection
03/21/2013CA2848999A1 Method for detecting bladder cancer cells, primer used in method for detecting bladder cancer cells, and bladder cancer marker
03/21/2013CA2848762A1 Method for treatment of disorders of the gastrointestinal system
03/21/2013CA2848654A1 Methylation analysis on self-samples as triage tool for hpv-positive women
03/21/2013CA2848608A1 Method and system for amplification of nucleic acids in microfluidic volume hydrogels
03/21/2013CA2848578A1 Sperm protein as a detection biomarker of early stage ovarian cancer
03/21/2013CA2848559A1 Method for inspecting susceptibility of bacteria or fungi to antimicrobial drug and system for use in the same
03/21/2013CA2848403A1 Hyr1-derived compositions and methods of treatment using same
03/21/2013CA2848371A1 Methods and compositions for weed control
03/21/2013CA2848240A1 Nucleic acid transcription method
03/21/2013CA2848162A1 Non-invasive methods of detecting target molecules
03/21/2013CA2844577A1 Microrna inhibitors